VSTM
Verastem
Stock NASDAQ – Stock Market Prices, News & Analysis
Verastem Inc focuses on the development and commercialization of drugs for the treatment of cancers, particularly hematologic cancers.
Verastem
VSTM
Verastem Inc focuses on the development and commercialization of drugs for the treatment of cancers, particularly hematologic cancers.
Price history of Verastem
Price history of Verastem
Performance & Momentum
Strategic Analysis
Verastem • 2026
Verastem Inc is an American biotechnology company specializing in the development of innovative treatments primarily targeting hematologic cancers. Its model relies on advanced clinical research to address unmet medical needs, positioning it in a niche segment with high therapeutic potential.
Strengths
- Deep expertise in hematologic cancers
- Pipeline focused on innovative targeted therapies
- Positioned in a high growth and high technology market
Weaknesses
- Disappointing long-term stock performance
- Lack of recent catalysts to reignite momentum
Momentum
Current momentum remains weak with a notable downward trend in the medium term, indicating resistances to overcome in the valuation. The absence of recent announcements limits investor interest who are monitoring for a potential clinical or commercial trigger to reverse this trend.
Similar stocks to Verastem
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
